Previous 10 | Next 10 |
2024-01-30 15:50:21 ET Dr Reddy's Laboratories Ltd. (RDY) Q3 2024 Earnings Conference Call January 30, 2024 10:00 AM ET Company Participants Richa Periwal - IR Parag Agarwal - CFO Erez Israeli - CEO Conference Call Participants Mikaela Franceschina - ...
2024-01-30 06:20:44 ET More on Dr. Reddy's Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Journey Medical submits NDA for DFD-29 for rosacea Dr. Reddy's acquires MenoLabs business from Amyris Seeking Alpha’s Quan...
2024-01-29 10:34:27 ET More on Dr. Reddy's Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Journey Medical submits NDA for DFD-29 for rosacea Dr. Reddy's acquires MenoLabs business from Amyris Seeking Alpha’s Quan...
2024-01-29 10:20:56 ET Major earnings expected before the bell on Tuesday include: Corning ( GLW ) General Motors ( GM ) Marathon Petroleum ( MPC ) Pfizer ( PFE ) United Parcel Service ( UPS ) Read the full article on Seeking Alpha For...
FFW Corp. (FFWC) is expected to report for Q2 2024 ResMed Inc. (RMD) is expected to report $1.81 for Q2 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2023-12-31 ChoiceOne Financial Services Inc. (COFS) is expected to report $0.64 for Q4 2023 First ...
2024-01-23 15:00:40 ET More on GSK GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference (Transcript) AbbVie Vs. GSK: Dual Dominance In Pharma GSK - Greenshoots In The Horizon GSK sells off partial stake in Haleon for $1.2B GSK to sell 3.2% stake ...
2024-01-12 12:54:48 ET Summary Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' dividend yield is 3.97%, which is attractive becaus...
2024-01-11 01:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-05 09:20:37 ET More on Journey Medical, Dr. Reddy's, etc. The Strategic Evolution Of Journey Medical In Dermatological Care Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Journey Medical Corporation (DERM) Q3 2023 Earni...
2024-01-03 06:16:20 ET Dr. Reddy's Laboratories ( NYSE: RDY ) on Wednesday announced a deal to acquire a women's health and dietary supplements portfolio of brands from Amyris ( OTC:AMRSQ ) as part of the latter's Chapter 11 sales process. Terms of the deal were not disc...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart and a decrease in (afterload) due to arterial dilatation India is the first global territory where ...
Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, advanced cervical cancer, ovarian cancer and metastatic breast ...
2024-03-04 16:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...